SPYBIOTECH LIMITED

SPYBIOTECH

Pharmaceutical, biopharmaceutical and medicinal preparations and substances for the treatment of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases ; biological, chemical and biochemical reagents for medical use; vaccines; biologics, namely antigens, virus like particles, modified viruses, blood, blood components, cells, nucleic acids, genes, tissues and proteins; vaccine preparations; all of the foregoing for exclusive use in the vaccine and viral based therapeutics field;SPY BIOTECH;Chemical, biochemical and biological preparations for scientific, laboratory or medical research use; reagents for research purposes; molecular biology research preparations in the nature of chemical, biochemical and biological reagents; biological and chemical reagents in the nature of complexes of these molecules for research and for clinical and commercial; chemical, biochemical and biological preparations for use in the manufacture of vaccines; none of the foregoing for medical or veterinary purposes; all of the foregoing for exclusive use in the vaccine and viral based therapeutics field;Medical and pharmaceutical research services; biological research; development of pharmaceutical preparations and medicines; research and development relating to biologics and vaccines; providing medical and scientific research information in the field of pharmaceuticals and vaccines; scientific research in the nature of conducting clinical trials for others in the vaccine and viral based therapeutics field; scientific and medical research consulting services in the nature of clinical trial design for vaccines for others; providing a bioinformatics platform for use in manufacturing therapeutics in the nature of platform as a service (PAAS) featuring computer software for medical data analysis; scientific services relating to the discovery, preclinical and clinical development of vaccines and therapeutic products in the nature of development of pharmaceutical preparations and medicines; research and development of new products for others; development of pharmaceutical products for others; information, advisory and consultancy services relating to the aforesaid;